ClinicalTrials.gg
CompletedNCT07512310NIPRESSUpdated Apr 6, 2026

Non-Invasive and Invasive Assessment of Heart Filling Pressure

An observational study in Heart Failure, Pulmonary Hypertension and Ventricular Dysfunction, Left, sponsored by University Hospital, Essen. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by University Hospital, Essen · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
623
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates how different non-invasive and invasive measurements reflect left ventricular filling pressure, an important indicator of cardiac function. Elevated filling pressure is associated with symptoms such as shortness of breath and plays a central role in the diagnosis and management of heart failure and pulmonary hypertension.

In clinical practice, filling pressure can be estimated using echocardiography or measured during cardiac catheterisation. However, the relationships between these measurements and their ability to accurately reflect true filling pressure are not fully understood.

This retrospective study includes patients who underwent cardiac catheterisation with invasive haemodynamic assessment and temporally related echocardiographic evaluation as part of routine clinical care. The aim is to improve understanding of how different measurements relate to each other and to identify which parameters best reflect elevated filling pressure.

The results are expected to support more accurate interpretation of haemodynamic measurements and improve clinical decision-making, particularly regarding the use of non-invasive versus invasive assessment.

02

Conditions studied

  • Heart Failure
  • Pulmonary Hypertension
  • Ventricular Dysfunction, Left
  • Ventricular Dysfunction
03

In context

Heart Failure

6,331 studies on the registry are indexed under Heart Failure; 1,396 are open to participants now.

This study's enrollment of 623 is above the median of 200 across 1,983 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University Hospital, Essen is the lead sponsor of 118 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Consecutive adult patients undergoing clinically indicated left- and right-heart catheterisation at the West German Heart and Vascular Centre Essen, University Hospital Essen, Germany, with available invasive haemodynamic measurements and echocardiographic assessment as part of routine clinical care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years)
  • Clinically indicated left- and right-heart catheterisation under resting conditions
  • Availability of invasive left ventricular end-diastolic pressure (LVEDP) measurement
  • Availability of pulmonary capillary wedge pressure (PCWP) measurement
  • Availability of transthoracic echocardiography within 5 days of cardiac catheterisation
  • Adequate echocardiographic image quality for analysis

Exclusion criteria

Exclusion Criteria:

  • Missing or incomplete invasive haemodynamic measurements (LVEDP or PCWP)
  • Missing or non-interpretable echocardiographic data
  • Haemodynamic instability at the time of measurement
  • Incomplete data required for analysis
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
623 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Accuracy of non-invasive and invasive parameters for identifying elevated left ventricular filling pressure

    Assessment of the ability of non-invasive and invasive surrogate parameters to identify elevated left ventricular filling pressure, with simultaneously obtained invasive left ventricular end-diastolic pressure serving as the reference standard

    Time frame: At the time of cardiac catheterisation (baseline)

07

Study locations

1 site
  • West German Heart and Vascular Centre Essen, University Hospital Essen
    Essen, Essen, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07512310
Responsible party
Sponsor
First posted
Apr 6, 2026
Start date
Mar 15, 2018
Primary completion
Mar 14, 2024
Completion
Mar 14, 2024
Last update
Apr 6, 2026
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion